Answers are grounded in this paper and cite their sources.
Demonstrates improved detection of fetal trisomy in prenatal samples, suggesting enhanced diagnostic accuracy.
Noninvasive prenatal testing (NIPT), which utilizes high-throughput sequencing technology to analyze cell-free DNA fragments from maternal peripheral plasma, has been widely adopted in clinical practice. However, accurately detecting fetal trisomy remains a challenge. To address this issue, we propose a novel double-layer ensemble model designed for detecting fetal trisomy13, 18 and 21. Firstly, we integrate the Synthetic Minority Oversampling Technique with K-Means clustering to augment positive samples, effectively balancing the training dataset. Subsequently, we implement feature selection algorithms to identify the optimal feature combination. Leveraging these enhancements, we develop a fast and accurate multi-class classification model FetalADM based on machine learning. Evaluate its performance on three independent test datasets: T54, T210, and T136. Notably, on the T54 dataset, FetalADM achieved a perfect 100% accuracy in detecting trisomy 21, 18, and 13. On the T210/T136 dataset, the model misclassified only 2/1 out of 210/136 samples (accuracy = 99.0%/99.3%), respectively, compared to 31/12 misclassifications by traditional bioinformatics methods. Specially, as a four-class classifier, FetalADM enables direct prediction of specific trisomy types, distinguishing itself from most binary-class models while maintaining high efficiency and accuracy. These results demonstrate that it outperforms conventional bioinformatics methods, underscoring its potential to improve the clinical diagnostic accuracy of fetal aneuploidies.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: